Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyReginster J-Y, Adami S, Lakatos P, et al (Univ of Lìege, Belgium; Univ of Verona, Italy; Semmelweis Univ, Budapest, Hungary; et al) Ann Rheum Dis 65:654–661, 2006§